2024-11-05 - Analysis Report
## UnitedHealth Group Inc (UNH) Stock Analysis

**1. Performance Comparison:**

UnitedHealth Group Inc (UNH) is a healthcare company, the largest health insurer in the United States. It has significantly outperformed the S&P 500 (VOO) with a cumulative return of **279.67%** compared to **131.28%** for the S&P 500. This represents a difference of **148.39%**, placing it in the **60.18th percentile** of its historical performance against the S&P 500.

**Alpha and Beta Analysis:**

| Year | CAGR | MDD | Alpha | Beta |
|------|------|-----|-------|------|
| 2015 | 16.7% | 12.4% | 17.5% | 1.0 |
| 2016 | 37.4% | 6.4% | 26.0% | 0.8 |
| 2017 | 36.5% | 4.8% | 17.9% | 0.9 |
| 2018 | 12.6% | 18.6% | 19.6% | 1.0 |
| 2019 | 20.7% | 19.5% | -7.9% | 0.7 |
| 2020 | 19.9% | 36.0% | 4.7% | 1.1 |
| 2021 | 43.7% | 11.0% | 14.9% | 0.7 |
| 2022 | 5.5% | 17.0% | 25.6% | 0.6 |
| 2023 | 1.5% | 14.6% | -23.3% | 0.3 |
| 2024 | 3.4% | 19.1% | -17.3% | 0.1 |

The table indicates that UNH has generally outperformed the market (Alpha > 0), demonstrating consistent positive returns.  The beta values, fluctuating around 1, suggest moderate market sensitivity.

**2. Recent Price Action:**

* **Closing price:** 557.77
* **Last market price:** 557.86
* **5-day moving average:** 562.98
* **20-day moving average:** 572.44
* **60-day moving average:** 580.68

The price is currently trading below all three moving averages, suggesting a potential short-term downtrend.

**3. Technical Indicators:**

* **RSI:** 51.25 - The RSI is currently in neutral territory, suggesting neither overbought nor oversold conditions.
* **PPO:** -0.15 - The PPO is slightly negative, indicating a weak short-term momentum.
* **Delta_Previous_Relative_Divergence:** -7.77 - This indicates a short-term downtrend in the relative performance compared to the S&P 500.
* **Expected Return:** 53.37% - This indicates a projected long-term (2+ years) outperformance relative to the S&P 500, assuming a continued trend of outperformance.

**4. Recent Earnings and Outlook:**

| Date | EPS | Revenue |
|---|---|---|
| 2024-11-04 | 6.56 | 100.82 B$ |
| 2024-08-09 | 4.58 | 98.86 B$ |
| 2024-05-09 | -1.53 | 99.80 B$ |
| 2023-11-06 | 6.31 | 92.36 B$ |
| 2024-11-04 | 6.31 | 92.36 B$ |

The most recent earnings report for Q3 2024 (released on 2024-11-04) showed an EPS of 6.56, exceeding analysts' expectations. Revenue also exceeded expectations. The company's consistent strong performance, despite recent market volatility, signals confidence in its long-term growth trajectory.

**5. Financial Information:**

**1) Revenue and Profitability:**

| Quarter | Revenue  | Profit Margin |
|---|---|---|
| 2024-06-30 | $97.86B | 21.52% |
| 2024-03-31 | $98.78B | 22.26% |
| 2023-12-31 | $93.25B | 22.33% |
| 2023-09-30 | $91.36B | 24.51% |
| 2023-06-30 | $91.79B | 23.72% |

UNH consistently generates significant revenue with strong profit margins. This demonstrates its ability to manage costs efficiently and capitalize on its dominant market position. 

**2) Capital and Profitability:**

| Quarter | Equity | ROE |
|---|---|---|
| 2024-06-30 | $89.36B | 4.72% |
| 2024-03-31 | $86.69B | -1.63% |
| 2023-12-31 | $88.76B | 6.15% |
| 2023-09-30 | $84.49B | 6.91% |
| 2023-06-30 | $82.35B | 6.65% |

Equity levels are consistently high, indicating financial stability. While ROE fluctuates, it remains generally strong, reflecting efficient capital utilization.

**6. News and Recent Events:**

(Please provide recent news and events for further analysis.)

**7. Analyst Opinions and Performance Highlights:**

(Please provide recent analyst opinions and performance highlights from sources like FINBOLD.)

**8. Overall Analysis:**

UNH demonstrates strong historical performance, consistently outperforming the S&P 500. The company has a solid financial foundation with consistent revenue generation and strong profitability. Recent earnings show continued growth and exceed market expectations. While short-term technical indicators suggest a potential downturn, the company's strong fundamentals and long-term prospects suggest a positive outlook. The expected return of 53.37% highlights the potential for outperformance in the long term.

**9. Report:**

This report provides a comprehensive analysis of UnitedHealth Group Inc (UNH), highlighting its strong performance, solid financial position, and positive outlook. The company's consistent outperformance, driven by a strong market position and efficient operations, makes it a compelling investment opportunity, particularly for long-term investors. While short-term fluctuations in the market may impact its price, UNH's fundamentals and strong track record suggest a positive long-term trajectory. 
